Jennifer Wargo, MD

Articles by Jennifer Wargo, MD

Determining the Role of the Gut Microbiome in Melanoma Treated With Anti–PD-1 ICIs

June 6th 2018

Patients who responded to anti–PD-1 therapy and experienced prolonged progression-free survival had a much greater diversity of gut bacteria.

Role of Gut Microbiome in Metastatic Melanoma Patients on Immunotherapy

ByJennifer Wargo, MD

June 27th 2017

In this interview we discuss the effect of the gut microbiome on responses and survival outcomes in metastatic melanoma patients treated with anti–PD-1 immunotherapies.

Latest Updated Articles

Role of Gut Microbiome in Metastatic Melanoma Patients on Immunotherapy
June 27th 2017
Determining the Role of the Gut Microbiome in Melanoma Treated With Anti–PD-1 ICIs
June 6th 2018

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

Achieving a “Functional Cure” With Multiple Myeloma Therapy

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)